Document Detail


Percutaneous epicardial ablation of ventricular tachycardia after failure of endocardial approach in the pediatric population with arrhythmogenic right ventricular dysplasia.
MedLine Citation:
PMID:  20601157     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
BACKGROUND: Despite the high efficacy of catheter ablation of ventricular tachycardia (VT) in patients with arrhythmogenic right ventricular dysplasia (ARVD), in some patients, conventional endocardial ablation is ineffective. These failures could be explained by the presence of epicardial arrhythmogenic substrate. In these cases, a percutaneous epicardial ablation may be required.
OBJECTIVE: This study sought to report the feasibility and results of epicardial VT ablation in a pediatric population of ARVD patients in whom endocardial ablation was unsuccessful.
METHODS: Seventeen ARVD pediatric patients (mean age 14 ± 4 years) in whom a percutaneous epicardial radiofrequency ablation of VT was attempted were included in this retrospective analysis. A total of 20 mappable, hemodynamically stable, monomorphic VTs were induced (2 macroreentrant and 18 focal). All patients underwent right ventricular epicardial VT ablation.
RESULTS: At the end of the procedure, 16 (94.1%) of the 17 patients had no inducible VT. Pericardial effusion occurred in 4 patients (23.5%), with 1 (5.9%) patient having tamponade that required percutaneous pericardial drainage. During a mean follow-up of 26 ± 15 (range 6 to 42) months, 12 (70.6%) patients remained free of any episodes of VT. All patients with successful RF ablation were free from any antiarrhythmic drugs. There were no deaths during the follow-up period. Recurrences of VT were recorded in 5 (29.4%) patients.
CONCLUSION: Percutaneous epicardial catheter ablation is feasible and relatively safe in pediatric ARVD patients with recurrent VT in whom conventional endocardial ablation failed.
Authors:
Evgeny Pokushalov; Alexandr Romanov; Alex Turov; Sergey Artyomenko; Natalya Shirokova; Alexander Karaskov
Related Documents :
3815927 - Prognostic significance of 24-hour ambulatory electrocardiographic monitoring in patien...
20885777 - C-reactive protein in arrhythmogenic right ventricular dysplasia/cardiomyopathy and rel...
3607587 - Pindolol therapy for bradycardia/tachycardia syndrome.
8447267 - Endocardial mapping during sinus rhythm in patients with coronary artery disease and no...
6742737 - The prognosis and possible cause of severe primary lymphoedema.
2039917 - Abnormalities of colonic mucin secretion and metabolic changes after internal urinary d...
Publication Detail:
Type:  Journal Article     Date:  2010-06-17
Journal Detail:
Title:  Heart rhythm : the official journal of the Heart Rhythm Society     Volume:  7     ISSN:  1556-3871     ISO Abbreviation:  Heart Rhythm     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-09-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101200317     Medline TA:  Heart Rhythm     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1406-10     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.
Affiliation:
Arrhythmia Department, State Research Institute of Circulation Pathology, Novosibirsk, Russia. E.Pokushalov@gmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Alteration of tyrosine kinase signaling: another player in the arrhythmogenesis of atrial fibrillati...
Next Document:  The nanoscopic range and the effect of architecture on nanoproperties.